Catalyst Wire Dossier Catalyst Wire Dossier

Cabotegravir (Apretude)

cabotegravir · ViiV Healthcare
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cabotegravir (Apretude), covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

See pricing